Positive selection on the Plasmodium falciparum sporozoite threonine-asparagine-rich protein: analysis of isolates mainly from low endemic areas

Gene
Somchai JongwutiwesHiroji Kanbara

Abstract

The sporozoite threonine-asparagine-rich protein (STARP) of Plasmodium falciparum is an attractive target for a pre-erythrocytic stage malaria vaccine because both naturally acquired and experimentally induced anti-STARP antibodies can block sporozoite invasion of hepatocytes. To explore the extent of sequence variation, we surveyed nucleotide polymorphism across the entire gene, encompassing 2 exons and an intron, of 124 P. falciparum-infected blood samples from Thailand and 10 from 4 other endemic areas. In total 24 haplotypes were identified despite low-level nucleotide diversity at this locus. The mean number of nonsynonymous substitutions per nonsynonymous site (d(N)) significantly exceeded that of synonymous substitutions per synonymous site (d(S)), suggesting that the STARP gene has evolved under positive selection, probably from host immune pressure. The preponderance of conservative amino acid exchanges and a strongly biased T-nucleotide toward the third position of codons in repeat arrays have reflected simultaneous constraints on this molecule, probably from its respective unknown function and nucleotide composition. Sequence conservation in the STARP locus among clinical isolates from different disease endemic areas...Continue Reading

References

Jun 20, 1991·Nature·J H McDonald, M Kreitman
Mar 1, 1972·Theoretical Population Biology·W J Ewens
Apr 1, 1995·Molecular and Biochemical Parasitology·M K Hughes, A L Hughes
Apr 1, 1994·Molecular and Biochemical Parasitology·D A FidockA Asavanich
Nov 1, 1994·The American Journal of Tropical Medicine and Hygiene·S JongwutiwesA L Hughes
Mar 1, 1993·Genetics·Y X Fu, W H Li
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·J ZhangM Nei
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S M RichF J Ayala
May 21, 1999·Molecular Biology and Evolution·F Verra, A L Hughes
Feb 16, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·G SnounouS Viriyakosol
Jul 6, 2000·Genetics·J C Fay, C I Wu
Aug 30, 2002·Molecular Biology and Evolution·Somchai JongwutiwesAustin L Hughes
Sep 11, 2002·The Lancet Infectious Diseases·Philippe J GuerinNicholas J White
Dec 12, 2003·Bioinformatics·Julio RozasRicardo Rozas
Jan 17, 2004·Lancet·Vasee S MoorthyAdrian V S Hill
Jan 11, 2005·Journal of Molecular Evolution·Austin L Hughes
May 10, 2005·Molecular and Biochemical Parasitology·Hannah E J PolsonShirley Longacre
Dec 13, 2005·Molecular and Biochemical Parasitology·Chaturong PutaporntipAustin L Hughes
May 10, 2007·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar

❮ Previous
Next ❯

Citations

Nov 27, 2015·Expert Review of Vaccines·Katie L FlanaganMagdalena Plebanski
Aug 15, 2014·Frontiers in Immunology·Alyssa E Barry, Alicia Arnott
Jan 28, 2017·Immunotherapy·Manuel E PatarroyoJorge Aza-Conde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.